Tonix Pharmaceuticals
TNXP
$0.17
Share price
5.31%
Change (1 day)
-61.70%
Change (1 year)
Categories
Tonix Pharmaceuticals (TNXP) - Total debt
Total debt on the balance sheet as of September 2023 : $1.15 M
According to Tonix Pharmaceuticals's latest financial reports the company's total debt is $1.15 M. A company’s total debt is the sum of all current and non-current debts.
Tonix Pharmaceuticals - Total debt on balance sheet (from 2011 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.76 M | -20.5% |
| 2021-12-31 | $0.95 M | -27.08% |
| 2020-12-31 | $1.31 M | 266.2% |
| 2019-12-31 | $0.35 M | |
| 2018-12-31 | $N/A | |
| 2013-12-31 | $0.28 M | |
| 2011-12-31 | $2.07 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Aerie Pharmaceuticals AERI | $0.33 B | 29,203.13% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $71.61 M | 6,127.39% | 🇺🇸 USA |